The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1487
Drugs for Rosacea
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

This common, chronic inflammatory facial eruption of unknown cause is more prevalent in women than in men. Rosacea is characterized by erythema and telangiectasia, and sometimes by recurrent, progressive crops of acneiform papules and pustules, usually on the central part of the face. Some patients develop granulomas and tissue hypertrophy, which may lead to rhinophyma (a bulbous nose), particularly in men. Blepharitis and conjunctivitis are common. Keratitis and corneal scarring occur rarely.

TOPICAL THERAPY — After starting treatment with topical drugs, it may take 4-6 weeks for improvement to become visible. Metronidazole (Metrogel, and others) and azelaic acid (Finacea for rosacea; Azelex for acne) are the standard topical antimicrobials used to treat the papules and pustules of rosacea; they appear to be about equally effective, but few ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Rosacea
Article code: 1487b
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian